MedPath

A pilot study to assess skeletal muscle protein synthesis rate after protein supplementatio

Not Applicable
Conditions
ormal healthy volunteers
Registration Number
JPRN-UMIN000037199
Lead Sponsor
ational Institute of Radiological Sciences (NIRS), QST
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
6
Inclusion Criteria

Not provided

Exclusion Criteria

1.Subjects took agents (H2 blocker, PPI, digestive enzyme medicine), an unregulated drug (stomachic, digestant) which might have an influence on this study on the day of the study 2.Subjects with serious traumatic disorder or locomotor injury/ disease in the femoral region 3.Subjects with severe or chronic physical complications/disorders 4.Subjects who is considered to have diabetes, liver dysfunction, renal dysfunction, severe anemia, polycythemia, or diseases including infection, collagen disease, rheumatic fever, myocardial infarction, liver cirrhosis, sepsis, malignancy, viral disease, acute hepatitis, encephalitis, and endocrine disease by doctors with responsibilities in this study 5.Subjects with a milk allergy or lactose intolerance 6.Subjects with smoking habituation 7.Subjects who continue mild to intensive exercise habituation (i.e. 30 minutes a day, twice a week more than one year) 8.Subjects with claustrophobia 9.Subjects who participated in any other clinical trials for one month before this study 10.From the standpoint of radiation exposure from a nuclear medicine scan, subjects who received radiological examination such as X-rays, CT, PET, DEXA as clinical practice other than medical check-up in 12 months, or who have participated in other nuclear medicine scans as healthy volunteers in 6 months prior to the start of this study 11. Subjects who are considered to be inappropriate for participation by doctors with responsibilities in this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath